To determine if down-regulation of MIG-6 expression was affected by epigenetic modification in its promoter, we treated lung cancer and melanoma cell lines with inhibitors of methylation and histone deacetylation and then determined how those inhibitors influenced MIG-6 expression. The gene discussed is ERRFI1; the disease is lung cancer.